A Complete Enterprise Workflow Platform and IMS

PathPresenter is an enterprise image management and workflow platform for digital pathology, empowering clinical care, remote consultations, research, and education. We are on a mission to democratize pathology knowledge by connecting pathologists with global expertise and providing seamless access to cutting-edge AI models.

Our SaaS platform is secure, scalable, and vendor-agnostic, effortlessly integrating into any hospital or research infrastructure. Founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh, our platform has been built by pathologists for pathologists. With over 200,000 hours of real-world usage and tens of thousands of users worldwide, PathPresenter is trusted by major institutions and companies for its deep domain expertise and unmatched flexibility.

Why PathPresenter

Deep Domain Knowledge

Founded by decorated pathologist and digital pioneer Dr. Raj Singh, PathPresenter is built to give practicing pathologists exactly what they need

Unmatched Platform Flexibility

100% vendor-agnostic platform that integrates seamlessly with best-in-breed scanners, storage, AI, and LIS from 3rd party vendors, optimizing interoperability

Real World Experience

200,000+ hours of real- world usage; tens of thousands of users; large scale enterprise deployments at leading institutions

Management Team

Patrick Myles, MBA

Chief Executive Officer

Patrick is the CEO of PathPresenter. Previously, he was CEO of Huron Digital Pathology, and Vice President of Business Development for Teledyne DALSA. He served as a board member of the Digital Pathology Association.

Rajendra Singh, MD

Co-founder

Dr. Singh is Director of Dermatopathology at Summit Health and co-founder of PathPresenter. He serves as a member of the Digital and Computational Pathology Committee of the CAP, Editorial Board of the WHO for Classification of tumors, 5th Edition and the Board of Digital Pathology Association.

Cory Batenchuk, PhD

Senior Vice President, Operations and Co-founder

Dr. Batenchuk is a leading diagnostic device developer and co-founder of PathPresenter. He was technical program manager for Verily’s digital pathology efforts in oncology, establishing their CLIA facility for COVID-19 testing. He also served as an associate director for the immunotherapy diagnostic program at Bristol Myers Squibb.

KV Acharya, MCA

System Architect and Co-founder

KV Acharya is the chief architect and security professional at the Technology & Information Department at Delaware State and cofounder of PathPresenter. He has more than 15 years of experience in leading large, medium, and small-scale IT projects.

Senior Advisors

Matthew Hanna, MD

Vice Chair of Pathology Informatics, University of Pittsburgh Medical Center

Anil Parwani, MD, PhD

Chair of the Department of Pathology, The Ohio State University Hospital

Mahul B. Amin, MD

Vice President and Divisional Medical Director, Labcorp

A robust and secure platform for your enterprise

PathPresenter is an enterprise workflow platform that runs on the industry’s leading cloud service providers, ensuring the very best in imaging performance and data integrity, with ability to operate in a hybrid data environment. With 200,000+ hours of real world use, our platform is monitored 24/7 by industry-leading security and compliance vendor, Vanta, for HIPAA compliance. PathPresenter security is routinely assessed and validated by our partners, where our security model builds upon many proven technologies to ensure the protection of your data.

Want to learn more about PathPresenter?

The PathPresenter Clinical Viewer is a digital pathology image viewing and management software. It is approved for research use only and has not been cleared by the FDA as a medical device. It is the responsibility of a qualified pathologist to employ appropriate procedures and safeguards to assure the validity of the interpretation of images obtained using this device. Pathologists should exercise professional judgment in each clinical situation and examine the glass slides by conventional microscopy if there is doubt about the ability to accurately render an interpretation using this device alone.